DENISE R NEBGEN, M.D.
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas K7840
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about DENISE R NEBGEN at radaris.comName
Address
Phone
2410 Newbridge Ct, Pearland, TX 77584
5963 E Us Highway 290, Fredericksbrg, TX 78624
1754 Brandenburg Dr, San Antonio, TX 78232
5963 Us Highway 290, Fredericksbrg, TX 78624
5963 Us Highway 290, Fredericksburg, TX 78624
Professional information
Dr. Denise R Nebgen - MD (Doctor of Medicine)
Hospitals:
1155 Pressler St SUITE 1362, Houston 77030
1155 Pressler St SUITE 1362, Houston 77030
1155 Pressler St SUITE 1362, Houston 77030
Education:
Medical Schools
Northwestern University The Feinberg School Of Medicine
Northwestern University The Feinberg School Of Medicine
Physician Obstetrician Gynecologist At The Methodist Hospital
Position:
Physician Obstetrician Gynecologist at The Methodist Hospital
Location:
Houston, Texas Area
Industry:
Hospital & Health Care
Work:
The Methodist Hospital
-
Physician Obstetrician Gynecologist
Denise R Nebgen, Houston TX
Specialties:
OB-GYN
Address:
6550 Fannin St, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Education:
Doctor of Medicine
Doctor of Philosophy
Doctor of Dental Surgery
Doctor of Philosophy
Doctor of Dental Surgery
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology
Chondrogenic And Osteogenic Inducing Molecule
US Patent:
6677306, Jan 13, 2004
Filed:
May 16, 2001
Appl. No.:
09/744128
Inventors:
Arthur Veis - Skokie IL
Denise R. Nebgen - Houston TX
Denise R. Nebgen - Houston TX
Assignee:
Northwestern University - Evanston IL
International Classification:
A61K 3818
US Classification:
514 12, 530351, 530399, 536 235, 536 2351
Abstract:
The present invention is directed to methods of using and compositions comprising amelogenin peptides capable of inducing chondrogenesis and osteogenesis when implanted in vivo, a chondrogenesis in cultures in vitro. Compositions and methods of enhancing bone and cartilage growth using these peptides are described.